Karen Rosell

415 total citations
16 papers, 342 citations indexed

About

Karen Rosell is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Karen Rosell has authored 16 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Karen Rosell's work include Acute Myeloid Leukemia Research (8 papers), Retinoids in leukemia and cellular processes (4 papers) and Multiple Myeloma Research and Treatments (4 papers). Karen Rosell is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Retinoids in leukemia and cellular processes (4 papers) and Multiple Myeloma Research and Treatments (4 papers). Karen Rosell collaborates with scholars based in United States. Karen Rosell's co-authors include Jane L. Liesveld, Jeremy Bechelli, Chaohui Lü, Gordon L. Phillips, Camille N. Abboud, Camille N. Abboud, Myra Coppage, Joseph D. Rosenblatt, Gary Bridger and Aaron P. Rapoport and has published in prestigious journals such as Blood, The Journal of Immunology and Leukemia.

In The Last Decade

Karen Rosell

16 papers receiving 330 citations

Peers

Countries citing papers authored by Karen Rosell

Since Specialization

Citations

This map shows the geographic impact of Karen Rosell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Rosell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Rosell more than expected).

Fields of papers citing papers by Karen Rosell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Rosell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Rosell. The network helps show where Karen Rosell may publish in the future.

Co-authorship network of co-authors of Karen Rosell

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Rosell. A scholar is included among the top collaborators of Karen Rosell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Rosell. Karen Rosell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	A phase I study of decitabine and rapamycin in relapsed/refractory AML 2013 ·Leukemia Research ·Jane L. Liesveld, Kristen M. O’Dwyer, Alison Walker, Michael W. Becker, (unknown), Deborah Mulford, Rui Chen, Jeremy Bechelli, Karen Rosell, (unknown), Craig T. Jordan, Gordon L. Phillips	19
2	Cytotoxicity of Algae Extracts on Normal and Malignant Cells 2011 ·PubMed ·Jeremy Bechelli, Myra Coppage, Karen Rosell, Jane L. Liesveld	40
3	Proteasome Inhibition in Myelodysplastic Syndromes and Acute Myelogenous Leukemia Cell Lines 2011 ·Cancer Investigation ·Jane L. Liesveld, Karen Rosell, Jeremy Bechelli, Chaohui Lü, (unknown), Deborah Mulford, (unknown), Craig T. Jordan, Gordon L. Phillips	11
4	Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells 2007 ·Leukemia Research ·Jane L. Liesveld, Jeremy Bechelli, Karen Rosell, Chaohui Lü, Gary Bridger, Gordon L. Phillips, Camille N. Abboud	58
5	The mTOR Inhibitor Rapamycin Demonstrates Activity Against AML in Combination with Imatinib Mesylate and with 5-Azacytidine. 2007 ·Blood ·Jane L. Liesveld, Karen Rosell, Chaohui Lü, Deborah Mulford, Alison Walker	2
6	Acute myelogenous leukemia—microenvironment interactions: Role of endothelial cells and proteasome inhibition 2005 ·Hematology ·Jane L. Liesveld, Karen Rosell, Chaohui Lü, Jeremy Bechelli, Gordon L. Phillips, Jeffrey E. Lancet, Camille N. Abboud	33
7	Proteasome Inhibitor Combination with Cytarabine or Arsenic Trioxide Can Potentiate Apoptosis in AML Cells. 2005 ·Blood ·Jane L. Liesveld, Camille N. Abboud, Chaohui Lü, Jeremy Bechelli, Karen Rosell, Gordon L. Phillips, Jeffrey E. Lancet	2
8	The CXCR4 Antagonist, AMD3100, Inhibits AML Transmigratory Activity but Does Not Alter Blast Proliferation or Survival. 2004 ·Blood ·Jane L. Liesveld, Jeffrey E. Lancet, Karen Rosell, Jeremy Bechelli, Camille N. Abboud, Gordon L. Phillips	1
9	Flavonoid effects on normal and leukemic cells 2003 ·Leukemia Research ·Jane L. Liesveld, Camille N. Abboud, Chaohui Lü, (unknown), (unknown), Alan J. Smith, Karen Rosell, Aaron P. Rapoport	42
10	A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma 2003 ·Cancer Gene Therapy ·Alok A. Khorana, Joseph D. Rosenblatt, Deepak M. Sahasrabudhe, Thomas G. Evans, (unknown), (unknown), Karen Rosell, Theresa L. Whiteside, (unknown), Bruce Acres, Philippe Slos, Patrick Squiban, Mary Ellen Ross, Kari Kendra	49
11	Effects of the farnesyl transferase inhibitor R115777 on normal and leukemic hematopoiesis 2003 ·Leukemia ·Jane L. Liesveld, Jeffrey E. Lancet, Karen Rosell, (unknown), Nhan Lu-Chinh Phan, (unknown), Camille N. Abboud, Joseph D. Rosenblatt	17
12	Response of Human CD34 ⁺ Cells to CXC, CC, and CX ₃ C Chemokines: Implications for Cell Migration and Activation 2001 ·Journal of Hematotherapy & Stem Cell Research ·Jane L. Liesveld, Karen Rosell, Nicki Panoskaltsis, Todd Belanger, (unknown), Camille N. Abboud	21
13	Flavopiridol Induces Apoptosis and Caspase-3 Activation of a Newly Characterized Burkitt's Lymphoma Cell Line Containing Mutant P53 Genes 2001 ·Blood Cells Molecules and Diseases ·Aaron P. Rapoport, (unknown), Timothy F. Chen, (unknown), (unknown), Karen Rosell, Tom G. Obrig, David G. Hicks, Patricia M. Hinkle, Moon H. Nahm, Richard A. Insel, Camille N. Abboud	16
14	MIP-1α and TGF-β Production in CD34+ Progenitor–Stromal Cell Coculture Systems: Effects of Progenitor Isolation Method and Cell–Cell Contact 2000 ·Blood Cells Molecules and Diseases ·Jane L. Liesveld, (unknown), Todd Belanger, Karen Rosell, Camille N. Abboud	5
15	Effects of anti-oxidants on normal and leukemic hematopoiesis 2000 ·Experimental Hematology ·Jane L. Liesveld, (unknown), Karen Rosell, Alan J. Smith, Camille N. Abboud	1
16	A RANTES-Antibody Fusion Protein Retains Antigen Specificity and Chemokine Function 1998 ·The Journal of Immunology ·Pia M. Challita-Eid, Camille N. Abboud, Sherie L. Morrison, Manuel L. Penichet, Karen Rosell, (unknown), Shannon P. Hilchey, Vicente Planelles, Joseph D. Rosenblatt	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact